Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Quarterly Period Ended January 2, 2005

 

or

 

¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from              to             

 

Commission File No. 0-8866

 


 

MICROSEMI CORPORATION

(Exact name of registrant as specified in its charter)

 


 

Delaware   95-2110371

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

2381 Morse Avenue, Irvine, California 92614

(Address of principal executive offices) (Zip Code)

 

(949) 221-7100

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

The number of shares of the issuer’s Common Stock, $0.20 par value, outstanding on January 31, 2005 was 61,087,798.

 



Table of Contents

Table of Contents

 

Reference


        Page

PART I.

   FINANCIAL INFORMATION     

ITEM 1.

   Financial Statements     
    

Unaudited Consolidated Balance Sheets as of September 26, 2004 and January 2, 2005

   4
    

Unaudited Consolidated Income Statements for the Quarters Ended December 28, 2003 and January 2, 2005

   5
    

Unaudited Consolidated Statements of Cash Flows for the Quarters Ended December 28, 2003 and January 2, 2005

   6
    

Notes to Unaudited Consolidated Financial Statements

   7

ITEM 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    14

ITEM 3.

   Quantitative and Qualitative Disclosures about Market Risk    34

ITEM 4.

   Controls and Procedures    34

PART II.

   OTHER INFORMATION     

ITEM 6.

   Exhibits    35

 

2


Table of Contents

PART I - FINANCIAL INFORMATION

 

Item 1. FINANCIAL STATEMENTS

 

The unaudited consolidated income statements for the three months ended January 2, 2005 of Microsemi Corporation and Subsidiaries (which we herein sometimes refer to collectively as “Microsemi”, “the Company”, “we”, “our”, “ours” or “us”), the unaudited consolidated statements of cash flows for the three months ended January 2, 2005, and the comparative unaudited consolidated financial information for the corresponding period of the prior year, together with the unaudited balance sheets as of January 2, 2005 and as of September 26, 2004, are included herein.

 

3


Table of Contents

MICROSEMI CORPORATION AND SUBSIDIARIES

Unaudited Consolidated Balance Sheets

(amounts in thousands, except per share data)

 

     September 26,
2004


   

January 2,

2005


 

ASSETS

                

Current assets:

                

Cash and cash equivalents

   $ 45,118     $ 49,669  

Accounts receivable, net of allowance for doubtful accounts, $1,361 at September 26, 2004 and $1,379 at January 2, 2005

     42,219       44,793  

Inventories

     54,555       54,901  

Deferred income taxes

     8,490       8,490  

Other current assets

     1,979       2,090  
    


 


Total current assets

     152,361       159,943  

Property and equipment, net

     59,098       58,080  

Deferred income taxes

     8,772       8,772  

Goodwill

     3,258       3,258  

Other intangible assets, net

     5,411       5,181  

Other assets

     4,098       4,066  
    


 


TOTAL ASSETS

   $ 232,998     $ 239,300  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY

                

Current liabilities:

                

Notes payable

   $ 121     $ 181  

Current maturity of long-term liabilities

     677       587  

Accounts payable

     17,012       13,556  

Accrued liabilities

     21,779       17,536  

Income taxes payable

     4,315       6,947  
    


 


Total current liabilities

     43,904       38,807  
    


 


Long-term liabilities

     4,217       3,765  
    


 


Stockholders’ equity:

                

Preferred stock, $1.00 par value; authorized 1,000 shares; none issued

     —         —    

Common stock, $0.20 par value; authorized 100,000 shares; issued and outstanding 59,830 and 61,075 at September 26, 2004 and January 2, 2005, respectively

     11,966       12,215  

Capital in excess of par value of common stock

     123,379       129,714  

Retained earnings

     49,551       54,818  

Accumulated other comprehensive loss

     (19 )     (19 )
    


 


Total stockholders’ equity

     184,877       196,728  
    


 


TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

   $ 232,998     $ 239,300  
    


 


 

The accompanying notes are an integral part of these statements

 

4


Table of Contents

MICROSEMI CORPORATION AND SUBSIDIARIES

Unaudited Consolidated Income Statements

(amounts in thousands, except earnings per share)

 

     Quarter Ended

 
    

December 28,

2003


  

January 2,

2005


 

Net sales

   $ 54,945    $ 69,754  

Cost of sales

     36,763      45,738  
    

  


Gross profit

     18,182      24,016  
    

  


Operating expenses:

               

Selling, general and administrative

     9,707      10,796  

Research and development

     4,750      4,871  

Amortization of intangible assets

     302      229  

Restructuring charges

     —        360  
    

  


Total operating expenses

     14,759      16,256  
    

  


Operating income

     3,423      7,760  
    

  


Other income (expense):

               

Interest, net

     78      117  

Other, net

     12      (16 )
    

  


Total other income

     90      101  
    

  


Income before income taxes

     3,513      7,861  

Provision for income taxes

     1,159      2,594  
    

  


NET INCOME

   $ 2,354    $ 5,267  
    

  


Earnings per share:

               

Basic

   $ 0.04    $ 0.09  
    

  


Diluted

   $ 0.04    $ 0.08  
    

  


Common and common equivalent shares outstanding:

               

Basic

     58,379      60,336  
    

  


Diluted

     61,402      64,154  
    

  


 

The accompanying notes are an integral part of these statements.

 

5


Table of Contents

MICROSEMI CORPORATION AND SUBSIDIARIES

Unaudited Consolidated Statements of Cash Flows

(amounts in thousands)

 

     Quarter Ended

 
    

December 28,

2003


   

January 2,

2005


 

Cash flows from operating activities:

                

Net income

   $ 2,354     $ 5,267  

Adjustments to reconcile net income to net cash provided by operating activities:

                

Depreciation and amortization

     2,943       3,411  

Provision for doubtful accounts

     24       68  

Loss on dispositions and retirements of assets

     7       44  

Changes in assets and liabilities:

                

Accounts receivable

     (32 )     (2,642 )

Inventories

     (80 )     (346 )

Other current assets

     (156 )     (111 )

Accounts payable

     (339 )     (3,456 )

Accrued liabilities

     502       (4,243 )

Income taxes payable

     1,134       2,632  

Other long-term liabilities

     (64 )     —    
    


 


Net cash provided by operating activities

     6,293       624  
    


 


Cash flows from investing activities:

                

Purchases of property and equipment

     (1,857 )     (2,207 )

Changes in other assets

     (58 )     32  
    


 


Net cash used in investing activities

     (1,915 )     (2,175 )
    


 


Cash flows from financing activities:

                

Increase in notes payable

     —         60  

Payments of long-term liabilities

     (13 )     (542 )

Exercise of employee stock options

     1,899       6,584  
    


 


Net cash provided by financing activities

     1,886       6,102  
    


 


Net increase in cash and cash equivalents

     6,264       4,551  

Cash and cash equivalents at beginning of period

     29,353       45,118  
    


 


Cash and cash equivalents at end of period

   $ 35,617     $ 49,669  
    


 


 

The accompanying notes are an integral part of these statements.

 

 

6


Table of Contents

MICROSEMI CORPORATION AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

January 2, 2005

 

1. PRESENTATION OF FINANCIAL INFORMATION

 

The unaudited consolidated financial statements include the accounts of Microsemi Corporation and its subsidiaries (which we herein sometimes refer to collectively as “Microsemi”, “the Company”, “we”, “our”, “ours” or “us”). Intercompany transactions have been eliminated in consolidation.

 

The financial information furnished herein is unaudited, but in the opinion of our management, includes all adjustments (all of which are normal, recurring adjustments) necessary for a fair presentation of the results of operations for the periods indicated. The results of operations for the first quarter ended January 2, 2005 of the current fiscal year are not necessarily indicative of the results to be expected for the full year.

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q, and therefore do not include all information and note disclosures necessary for a fair presentation of financial position, results of operations and cash flows in conformity with generally accepted accounting principles. The unaudited consolidated financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto in the Annual Report on Form 10-K for the fiscal year ended September 26, 2004.

 

Critical Accounting Policies and Estimates

 

The unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States that require us to make estimates and assumptions that materially affect the reported amounts of assets and liabilities at the date of the unaudited consolidated financial statements and revenues and expenses during the periods reported. Actual results could differ from those estimates.

 

2. INVENTORIES

 

Inventories used in the computation of cost of goods sold were (amounts in thousands):

 

    

September 26,

2004


  

January 2,

2005


Raw materials

   $ 13,289    $ 13,442

Work in process

     28,244      25,779

Finished goods

     13,022      15,680
    

  

     $ 54,555    $ 54,901
    

  

 

3. CONTINGENCY

 

In Broomfield, Colorado, the owner of a property located adjacent to a manufacturing facility owned by Microsemi Corp. - Colorado (“the Subsidiary”) had notified the subsidiary and other parties, of a claim that contaminants migrated to his property, thereby diminishing its value. In August 1995, the subsidiary, together with Coors Porcelain Company, FMC Corporation and Siemens Microelectronics, Inc. (former owners of the manufacturing facility), agreed to settle the claim and to indemnify the owner of the adjacent property for remediation costs. Although TCE and other contaminants previously used by former owners at the facility are present in soil and groundwater on the subsidiary’s property, we vigorously contest any assertion that the subsidiary caused the contamination. In November 1998, we signed an agreement with the three former owners of this facility whereby they have 1) reimbursed us for $530,000 of past costs, 2) assumed responsibility for 90% of all future clean-up costs, and 3) promised to indemnify and protect us against any and all third-party claims relating to the contamination of the facility. An Integrated Corrective Action Plan was submitted to the State of Colorado. Sampling and management plans were prepared for the Colorado Department of Public Health & Environment. State

 

7


Table of Contents

and local agencies in Colorado are reviewing current data and considering study and cleanup options. The most recent forecast estimated that the total project cost, up to the year 2020, would be approximately $5,300,000; accordingly, by assuming that this amount is accurate and that the indemnifying parties will pay 90% of this amount as agreed without need for us to incur material costs to enforce that agreement, we reserved for this contingency by recording a one-time charge of $530,000 for the life of this project in fiscal year 2003. There has not been any significant development since September 28, 2003.

 

On October 7, 2004, we filed a complaint in the United States District Court for the Central District of California entitled Microsemi Corporation v. Monolithic Power Systems, Inc., Case Number SACV04-1174 CJC (Anx). The Complaint alleges infringement of Microsemi patents and seeks an injunction, actual damages, treble damages, declaratory relief and attorneys’ fees. The defendant filed a cross-claim for declaratory relief and attorneys’ fees. We are in the early stage of this litigation and unable to assess the possible outcome of this litigation.

 

We are involved also in other normal litigation matters, arising out of the ordinary routine conduct of our business, including from time to time litigation relating to commercial transactions, contracts, and environmental matters. In the opinion of management, the final outcome of these matters will not have a material adverse effect on our financial position, results of operations or cash flows.

 

4. COMPREHENSIVE INCOME

 

Comprehensive income is defined as the change in equity (net assets) of a business enterprise during the period from transactions and other events and circumstances from non-owner sources. Our comprehensive income consists of net income and the change of the cumulative foreign currency translation adjustment. Accumulated other comprehensive loss consists of the cumulative foreign currency translation adjustment. Total comprehensive income for the quarters ended December 28, 2003 and January 2, 2005 were calculated as follows (amounts in 000’s):

 

     Quarters Ended

     December 28,
2003


    January 2,
2005


Net income

   $ 2,354     $ 5,267

Translation adjustment

     (9 )     —  
    


 

Comprehensive income

   $ 2,345     $ 5,267
    


 

 

5. EARNINGS PER SHARE

 

Basic earnings per share have been computed based upon the weighted average number of common shares outstanding during the respective periods. Diluted earnings per share have been computed, when the result is dilutive, using the treasury stock method for stock options outstanding during the respective periods.

 

Earnings per share (“EPS”) for the respective quarters ended December 28, 2003 and January 2, 2005 were calculated as follows (amounts in thousands, except per share data):

 

     Quarters Ended

     December 28,
2003


   January 2,
2005


BASIC

             

Net income

   $ 2,354    $ 5,267
    

  

Weighted-average common shares outstanding

     58,379      60,336
    

  

Basic earnings per share

   $ 0.04    $ 0.09
    

  

DILUTED

             

Net income

   $ 2,354    $ 5,267
    

  

Weighted-average common shares outstanding for basic

     58,379